## Summary

ProteinVista is a 3D CNN that voxelizes every heavy atom at 1Å resolution into 5-channel density grids, pre-trained on ~500k AlphaFold-2 structures via contrastive alignment to ESM-2 embeddings or Rosetta physicochemical score regression. It achieves competitive or superior performance vs. ESM-2 on enzyme-substrate classification (ESP), transporter-substrate classification (TSP), and IC₅₀ affinity regression, with significant compute efficiency advantages. I have verified all claims in the rebuttal against the actual paper text.

---

## Rebuttal Assessment

### Weakness 1: Pre-training confound undermines "structure vs. sequence" comparison
- **Author's response:** Partially address
- **Assessment:** Partially convincing — The ablation in Section 4.2 is confirmed: "Replacing the contrastive alignment to ESM-2 embeddings with multi-task regression on 23 Rosetta energy terms decreased R² by 1.0%." At R² ≈ 0.683, the Rosetta-only variant would still substantially outperform ESM-2₆₅₀M (R² = 0.61), validating the core IC₅₀ claim. However, Figure 2e shows "~1.2%" for Rosetta vs. CL (slightly inconsistent with the 1.0% stated in Section 4.2), and the rebuttal itself alternates between these two figures. More critically, the author explicitly acknowledges "the Rosetta-pre-trained variant was evaluated only on IC₅₀ regression and not on the TSP and ESP classification benchmarks. This is a genuine gap." The paper provides no evidence that the pure structural signal drives the classification gains—only a promise to add Rosetta rows in revision, which does not count under review policy.
- **Score impact:** Weakness downgraded for IC₅₀ claim (genuine structural evidence exists), but weakness maintained for TSP and ESP (no evidence in paper; classification argument still depends on ESM-2-contaminated pre-training).

### Weakness 2: SOTA comparison margins are thin and lack statistical qualification
- **Author's response:** Partially address
- **Assessment:** Partially convincing for the MCC point—Table 1 confirms MCC 0.83 vs. 0.80 (TSP) and 0.86 vs. 0.85 (ESP), which are somewhat clearer than raw accuracy gaps. However, the author also **concedes** the pipeline asymmetry more explicitly than the original paper did: "claiming SOTA on the basis of an enriched pipeline applied only to our model is not methodologically equivalent to a controlled comparison." This is an honest acknowledgment that actually slightly *weakens* the paper's position versus the original review, since the author now explicitly admits the OP comparison is not head-to-head. No statistical tests are added to address the reviewer's concern—those are promised for revision. The author correctly notes that the non-OP ESM-ProteinVista ensemble (a genuinely comparable comparison) does not beat SPOT or ProSmith-ESP.
- **Score impact:** Weakness unchanged. The statistical gap is acknowledged but unfixed; the author's own concession confirms the pipeline asymmetry is real.

### Weakness 3: Abstract overstates ensemble benefit
- **Author's response:** Acknowledge
- **Assessment:** Convincing acknowledgment—Table 2 confirms ensemble R² = 0.68 vs. ProteinVista alone R² = 0.69, and Section 3.2 text already correctly notes the ensemble performs worse on IC₅₀. The proposed revised wording is appropriate. However, the submitted paper still contains the erroneous abstract.
- **Score impact:** Weakness unchanged (error is in the paper as submitted; the fix is only promised).

### Weakness 4: Inference-time compute claim is inconsistent
- **Author's response:** Acknowledge
- **Assessment:** Convincing acknowledgment—the author correctly identifies the contradiction: Section 4.3 says "during training" while Figure 3c's bar-chart title says "Inference Time on Single A100" (confirmed in paper: "Figure 3: Comparison of ProteinVista with ESM-2-150M and ESM-2-650M across four metrics: (a)...(c) Inference Time on Single A100"). The corrected figure caption says "training time to process 1 000 proteins." The author's rebuttal claim that 5-view inference gives ~100s vs. ESM-2₁₅₀M's 215s and ESM-2₆₅₀M's 426s is plausible and honest. Note that Figure 3c's bar shows ProteinVista at "approximately 10 seconds" while Section 4.3 says "20 seconds"—yet another internal inconsistency the rebuttal does not address.
- **Score impact:** Weakness unchanged (still in the submitted paper; also reveals a secondary text-figure inconsistency at ~10s vs. 20s).

### Weakness 5: BindingDB train/test split not described
- **Author's response:** Acknowledge
- **Assessment:** Unconvincing as a resolution—the paper refers readers to "Table S3" in supplementary (not included in main text), and the split methodology is genuinely absent from the main text as the reviewer identified. The rebuttal correctly notes this materially affects interpretation of the R² = 0.69 result. Promise to add to Section 3.1 in revision.
- **Score impact:** Weakness unchanged.

### Weakness 6: "Rotational invariance" overstated in Figure 1 caption
- **Author's response:** Acknowledge
- **Assessment:** Convincing acknowledgment—Figure 1 caption confirmed to say "To enforce rotational invariance" while Section 2.4 uses "rotation-robust." Promise to align terminology.
- **Score impact:** Trivial weakness unchanged (editorial fix promised but not done).

---

## Strengths
- **IC₅₀ regression improvement confirmed**: R² = 0.69 vs. 0.61 for ESM-2₆₅₀M, with Wilcoxon p < 10⁻³⁰⁴ (Table 2). This is the paper's most compelling result, and the ablation provides partial support that geometric encoding (not ESM-2 distillation) drives the gain for this task.
- **Ensemble complementarity with statistical qualification**: McNemar p < 10⁻¹³ (TSP) and p < 10⁻¹⁷ (ESP) for the ESM-ProteinVista ensemble vs. ESM-2₆₅₀M alone (Section 3.2), with complementarity confirmed across all similarity bins (Figure 2a–c).
- **Informative ablation design**: Multi-view inference contribution (6.4% R² drop for 1 view) vs. fine-tuning augmentation (-0.1%) cleanly isolates where rotation robustness is absorbed—an operationally novel finding.
- **Compute efficiency properly quantified**: 123M params, 48 GPU-hours on 4 A100s vs. 650M params, ~21,000 GPU-hours for ESM-2₆₅₀M (Section 4.3).
- **pLDDT stratification substantiates breadth of gains**: Figure 2c–d shows ProteinVista's advantage concentrated in high-confidence structures (pLDDT > 90), and Figure 2d confirms most test proteins fall in that regime.

---

## Weaknesses

### Fatal
None.

### Major

- **Pre-training confound for classification tasks remains unresolved**: The Rosetta-pre-trained variant (no ESM-2 signal) is evaluated *only* on IC₅₀ regression. The TSP and ESP classification benchmarks—where the "structure vs. sequence" claim is argued—are never evaluated with the Rosetta variant. The paper's central comparative claim for classification tasks therefore rests on a model whose weights were explicitly shaped by ESM-2 embeddings. The author concedes this is "a genuine gap" but provides no in-paper fix. The IC₅₀ structural argument is partially validated, but the classification argument is not.

- **SOTA comparison is methodologically compromised and now explicitly admitted**: The author's rebuttal concedes that ESM-ProteinVista_OP "is not methodologically equivalent to a controlled comparison" because it applies an enriched pipeline (contrastive fine-tuning + joint MolFormer fine-tuning) to ProteinVista/ESM-2 but not to SPOT, ProSmith-ESP, or Fusion_ESP. No statistical tests are provided for the SOTA margins (0.8 pp on TSP accuracy, 0.2 pp on ESP accuracy). The MCC margins are slightly clearer (3 pp for TSP, 1 pp for ESP), but remain unstatisticized. The author's candid acknowledgment of the pipeline problem is honest but damages the headline SOTA claims.

### Minor

- **Abstract inaccuracy persists**: States "A simple ensemble with ESM-2 can further improve accuracy" universally, but Table 2 confirms the ensemble *hurts* on IC₅₀ (R² = 0.68 vs. 0.69). Acknowledged but unfixed in submitted paper.

- **Figure 3c labeling inconsistency**: Bar-chart title says "Inference Time on Single A100" while Section 4.3 says "during training" and the corrected figure caption says "training time." An additional discrepancy exists: Figure 3c bar reads ~10s while Section 4.3 text says 20s. Actual 5-view inference cost (~100s) is not reported at all. Acknowledged but unfixed.

- **BindingDB split protocol absent from main text**: Main text refers only to "Table S3" in supplementary; split strategy materially affects IC₅₀ interpretability. Acknowledged but unfixed.

### Trivial

- **"Rotational invariance" vs. "rotation-robust" terminology mismatch** between Figure 1 caption and Section 2.4. Acknowledged, fix promised.
- **Minor internal ablation number inconsistency**: Section 4.2 says 1.0% and 6.4% for Rosetta vs. CL and 1-view vs. 5-view; Figure 2e shows ~1.2% and ~5.5% respectively. The rebuttal itself uses both figures without resolution.

---

## Nice-to-Haves
- Rosetta-pre-trained variant evaluated on all three tasks (Table 1 and 2) would cleanly test whether geometric encoding alone drives classification gains.
- Statistical tests for OP vs. SOTA comparisons would substantiate the headline claims.
- Explicit 5-view inference timing in Figure 3c or Section 4.3.
- BindingDB split strategy added to Section 3.1 main text.
- Grad-CAM visualization example demonstrating autonomous binding-site localization.

---

## Novel Insights

The most novel finding—unchanged by the rebuttal—is the dissociation between rotation augmentation during fine-tuning (-0.1% impact) and multi-view inference (-6.4% impact when reduced to 1 view), implying that rotation robustness is absorbed into pre-trained weights rather than task-specific fine-tuning. This has direct implications for efficient deployment of 3D CNN protein models. The stratification finding (ProteinVista advantage at high sequence identity and TM-score, ESM-2 relatively stronger at low identity) continues to suggest a mechanistically interpretable complementarity: geometric models interpolate within known folds, sequence models generalize across evolutionary distances.

---

## Suggestions
1. Add Rosetta-pre-trained variant rows to Table 1 (TSP and ESP) to resolve the central pre-training confound for classification.
2. Apply the OP pipeline improvements identically to at least one SOTA baseline (SPOT or Fusion_ESP) or add McNemar's tests for the existing OP vs. SOTA margins.
3. Correct the abstract to qualify that ensemble benefit is task-dependent.
4. Report 5-view inference timing explicitly in Section 4.3 and fix Figure 3c to remove the training-vs.-inference labeling conflict.
5. Add BindingDB split methodology to Section 3.1 main text.
6. Reconcile the 1.0% (Section 4.2 text) vs. ~1.2% (Figure 2e) ablation discrepancy for the Rosetta vs. CL comparison.

---

## Score and Decision

**Rebuttal impact assessment:**

| Weakness | Original weight | Rebuttal outcome |
|---|---|---|
| Pre-training confound (classification) | Major | Partially downgraded for IC₅₀; unchanged for TSP/ESP |
| SOTA comparison thin + unstatisticized | Major | Unchanged — author concession makes it slightly worse |
| Abstract inaccuracy | Minor | Unchanged (acknowledged, unfixed) |
| Inference-time inconsistency | Minor | Unchanged (acknowledged, unfixed; secondary inconsistency exposed) |
| BindingDB split missing | Minor | Unchanged (acknowledged, unfixed) |
| Rotational invariance terminology | Trivial | Unchanged |

The rebuttal is unusually candid: the author acknowledges virtually every weakness without defensive spin and provides honest concessions, including the admission that the SOTA OP comparison "is not methodologically equivalent." This honesty is commendable but does not resolve the weaknesses — it confirms them. The only genuine partial mitigation is the evidence that the Rosetta variant retains a ~0.07–0.08 absolute R² advantage over ESM-2₆₅₀M on IC₅₀, which partially addresses the pre-training confound for affinity prediction specifically.

Against the original calibration anchors, the paper remains between ProteinWorkshop (6.25) and AtomSurf (6.75): stronger than ProteinWorkshop on method novelty and empirical results, weaker than AtomSurf due to unresolved pre-training confound for classification and uncontrolled SOTA comparisons. The author's explicit concession that the OP pipeline comparison is not fair to SOTA baselines is a small further debit relative to the original review. The IC₅₀ partial vindication is a small credit.

Net change: approximately neutral, with a very slight downward pressure from the SOTA concession. Score maintained at **5.5**.

MY FINAL SCORE: <score>5.5</score>
MY FINAL DECISION: <decision>Accept</decision>